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COMMENT&RESPONSE
Recurrence of Reflux After Laparoscopic
Antireflux Surgery
To the Editor Dr Maret-Ouda and colleagues assessed the out-
come of laparoscopic antireflux surgery among 2655 patients
who underwent the operation in Sweden between 2005 and
2014.1 They defined failure as postoperative use of antireflux
medications or need for secondary antireflux surgery. The
overall failure rate was 17.7%, and female sex, older age, and
comorbidities were risk factors. Hospital volume of laparo-
scopic antireflux surgery was not associated with risk of
recurrent reflux. They concluded that the high rate of recur-
rent reflux diminishes some of the benefits of the operation.
The study has significant limitations that raise questions
about the validity of the findings and the soundness of
the conclusions.
First, many studies have shown that in the absence of
Barrett esophagus, preoperative symptoms and endoscopic
findings have a sensitivity for gastroesophageal reflux dis-
ease of only 58% to 70%.2,3 The authors did not provide
any information about the preoperative work up in this
cohort of patients. Second, the most common indication for
laparoscopic antireflux surgery is incomplete relief of symp-
toms with proton pump inhibitor therapy. Based on this
consideration, it is remarkable that 82.3% of patients after
surgery had complete control of symptoms without any
need for medications.
Third, symptoms are a poor indicator of recurrence of
reflux after laparoscopic antireflux surgery, suggesting the
need for objective evidence of recurrence of reflux before
prescribing acid-reducing medications.4,5 Galvani et al
showed that only 39% of patients with recurrent symptoms
after laparoscopic antireflux surgery had recurrent reflux
when esophageal function tests were performed.4 Further-
more, 68% of patients who were taking acid-reducing medi-
cations after surgery had a normal reflux status as deter-
mined by pH monitoring. Therefore, assessing failure based
Table. Prevalence of ASD in US Children and Adolescents, 2014-2016
Characteristic No. With ASD/Total ASD, % (95% CI)a P Value
Overall 711/30 502b 2.41 (2.17-2.65)
Age, y
3-11 403/17 267b 2.42 (2.11-2.72)
.93c
12-17 308/13 235b 2.40 (2.03-2.76)
Sex
Male 545/15 727b 3.54 (3.14-3.95)
<.001c
Female 166/14 775b 1.22 (0.98-1.47)
Race/ethnicityd
Hispanic 140/8111b 1.78 (1.41-2.15)
.01c
Non-Hispanic white 405/14 900b 2.71 (2.36-3.05)
Non-Hispanic black 89/4038b 2.36 (1.66-3.07)
Other 77/3453b 2.45 (1.75-3.14)
Geographic region
Northeast 145/4742b 3.05 (2.40-3.70)
.11c
Midwest 148/6058b 2.47 (1.93-3.01)
South 234/10 775b 2.21 (1.81-2.61)
West 184/8927b 2.24 (1.84-2.65)
ASD prevalence by year
2014 237/11 082 2.24 (1.89-2.59)
.23e2015 240/10 183 2.41 (1.98-2.84)
2016 234/9237 2.58 (2.14-3.01)
Abbreviation: ASD, autism spectrum
disorder.
a Prevalence estimates were
weighted.
bUnweighted number of participants
involving all 3 years.
c P value for overall differences in
prevalence by strata.
dRace and Hispanic ethnicity were
self-reported and classified based
on the 1997 Office of Management
and Budget Standards.
e P value for trend.
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on the use of antirefluxmedications overestimates the failure
rate. Fourth, for an operation that usually requires a 23-hour
stay, surgeon’s volume rather than the hospital volume
should be assessed.
In conclusion, we think that laparoscopic antireflux sur-
gery,whenperformed for theproper indicationsbyexpert sur-
geons, is an effective treatment as it offers complete relief of
symptoms to the majority of patients.
Marco G. Patti, MD
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In Reply We do not believe that our view of the use of anti-
reflux surgery is very different from that of Drs Patti and
Schlottmann, but we would like to respond to the 4 po-
tential limitations of the study that were brought to our
attention.
First, it is correct that we had no information about the
preoperative workup of each individual in this large cohort
of patients. However, it is mandatory to conduct a careful
preoperative assessment of each patient considered for anti-
reflux surgery in Sweden, including symptom assessment,
endoscopy, and 24-hour manometry and pH measure-
ment. Only patients with objectively verified gastroesopha-
geal reflux disease who have not benefited from medical
treatment with proton pump inhibitor are considered for
antireflux surgery. Second, we agree that antireflux surgery
is often conducted in individuals with particularly severe
symptoms or with incomplete relief of symptoms using
medical therapy. Considering this, we also agree that the
rate of reflux recurrence after antireflux surgery was indeed
low in our study, even lower than in most previous studies
on this topic, despite the complete follow-up of an unse-
lected cohort.
The third comment concerns our assessment of re-
currence of reflux after antireflux surgery. Assessing the
presence or absence of gastroesophageal reflux disease is
sometimes difficult, but both endoscopy and 24-hour pH
measurement have low sensitivity and specificity to assess
this disease. Assessment of reflux symptoms also has a lim-
ited specificity, but it has a considerably higher sensitivity.
Thus, current guidelines recommend that the diagnosis of
gastroesophageal reflux disease is best established using
typical reflux symptoms.1 Based on this, we believe that
reflux symptoms and use of antireflux medication are still
the best currently available means of defining reflux recur-
rence after antireflux surgery. Fourth, Patti and Schlottmann
suggest that surgeon volume would be a better assessment
than hospital volume when evaluating the role of annual
antireflux surgery volume. We did not have data on the indi-
vidual operating surgeon, and hospital volume is still a reli-
able measure of annual surgery volume. Additionally, sur-
geon volume and hospital volume usually correlate quite
strongly, particularly in Sweden where each department of
surgery that conducts laparoscopic antireflux surgery con-
tains very few surgeons specialized in antireflux surgery.
We agree that laparoscopic antireflux surgery is an excel-
lent andprobablyunderused treatment inmanypatientswith
gastroesophageal reflux disease, but patients and surgeons
should be aware of the risk of recurrence.
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Self-regulation of theMedical Profession
andMaintenance of Certification
To the EditorTheViewpoint1 regardingmaintenance of certifi-
cation (MOC) requirements and Texas Senate bill (SB) 1148
asked practicing physicians tomake a leap of faith thatmany
cannot accommodate. Unfortunately, that leapof faith is cen-
tral to the author’s argument.
As Dr Johnson pointed out, self-regulation is a core attri-
bute of the learned professions. It encompasses the responsi-
bility and authority to establish andenforce standards of edu-
cation, training, andpractice. Physicians routinelydefend that
responsibility and authority in advocating against the intru-
sion of all third parties (such as government, private insurers,
or hospital administrators) into the practice of medicine.
However, as evidenced by their comments at the Texas
Medical Association and American Medical Association
House of Delegates and at the committee hearings on
SB 1148, many physicians today simply do not acknowledge
the certifying boards as “self.” They are, instead, profit-
driven organizations beholden to their own financial
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